Tenax Therapeutics: Funding, Investors & Team (Oct 2026)
a specialty pharmaceutical firm with a primary therapeutic focus on pulmonary hypertension that focuses on finding and developing therapies to target cardio-pulmonary disorders with significant unmet medical need.
Tenax Therapeutics has raised $25.6M across 2 funding rounds on record, the most recent an undisclosed round of $15.6M announced in Feb 2023.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Tenax Therapeutics Company Profile and Key Stats
Latest funding round on record: Feb 2023.
Tenax Therapeutics Funding Rounds
Tenax Therapeutics raised $10.0M in a Post-IPO Equity announced in Jul 2021.
1.6 years later, an undisclosed round of $15.6M was announced in Feb 2023.
Tenax Therapeutics Founders and Leadership Team
Contact details for the Tenax Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Tenax Therapeutics Funding Compared to Other Biotechnology Startups
Tenax Therapeutics' latest round of $15.6M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Tenax Therapeutics in Biotechnology and Chapel Hill
Companies Similar to Tenax Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Tenax Therapeutics Funding FAQs
What does Tenax Therapeutics do?
a specialty pharmaceutical firm with a primary therapeutic focus on pulmonary hypertension that focuses on finding and developing therapies to target cardio-pulmonary disorders with significant unmet medical need.
How much funding has Tenax Therapeutics raised?
Tenax Therapeutics has raised $25.6M across 2 rounds on record. The most recent is an undisclosed round of $15.6M announced in Feb 2023.
When did Tenax Therapeutics last raise funding?
Tenax Therapeutics' most recent funding round on record is an undisclosed round of $15.6M, announced in Feb 2023.
Who is the CEO of Tenax Therapeutics?
Chris Giordano is listed as CEO at Tenax Therapeutics.
Where is Tenax Therapeutics headquartered?
Tenax Therapeutics is based in Chapel Hill, North Carolina, United States.
How many employees does Tenax Therapeutics have?
Tenax Therapeutics is in the 11-50 employee band.
How does Tenax Therapeutics' funding compare to other Biotechnology startups?
Tenax Therapeutics' latest round of $15.6M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Tenax Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Tenax Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.